Literature DB >> 7355676

Experimental brain tumors by transplacental ENU. Multifactorial study of the latency period.

D Schiffer, M T Giordana, A Mauro, G Racagni, F Bruno, S Pezzotta, P Paoletti.   

Abstract

Experimental cerebral tumors have been induced by transplacental ENU. The morphologic study of the brains of treated rats revealed that cellular hyperplasias appear at the 30th day of extrauterine life in the paraventricular white matter, i.e., before the already known "early neoplastic proliferations". Cytofluorimetric investigations failed to demonstrate differences between treated and control rats during the 1st month. On the contrary, adenylate cyclase activity is very high in that period. The duration of the latency period is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7355676     DOI: 10.1007/bf00690751

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  22 in total

1.  Methodological and instrumentational aspects of cytofluorometry.

Authors:  G Prenna; G Mazzini; S Cova
Journal:  Histochem J       Date:  1974-05

2.  Investigation of glial cells in semithin sections. 3. Transformation of subependymal cells into glial cells, as shown by radioautography after 3 H-thymidine injection into the lateral ventricle of the brain of young rats.

Authors:  J A Paterson; A Privat; E A Ling; C P Leblond
Journal:  J Comp Neurol       Date:  1973-05-01       Impact factor: 3.215

3.  Difference in the cyclic adenosine 3',5'-monophosphate levels in normal and transformed cells.

Authors:  J R Sheppard
Journal:  Nat New Biol       Date:  1972-03-01

4.  Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats.

Authors:  A Koestner; J A Swenberg; W Wechsler
Journal:  Am J Pathol       Date:  1971-04       Impact factor: 4.307

5.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

6.  Inhibition of cell growth in vitro by adenosine 3',5'-monophosphate.

Authors:  W L Ryan; M L Heidrick
Journal:  Science       Date:  1968-12-27       Impact factor: 47.728

7.  A quantitative study of cell proliferation in the subependymal layer of the adult rat brain.

Authors:  P D Lewis
Journal:  Exp Neurol       Date:  1968-02       Impact factor: 5.330

8.  Electrophysiological properties of ethylnitrosourea-induced, neoplastic neurogenic rat cell lines cultured in vitro and in vivo.

Authors:  O D Laerum; D F Hülser; M F Rajewsky
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

9.  Morphological transformation of Chinese hamster cells by dibutyryl adenosine cyclic 3':5'-monophosphate and testosterone.

Authors:  A W Hsie; T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

10.  Short and long term effects of methyl- and ethylnitrosourea (MNU & ENU) on the developing nervous system of the rat. I. Long term effects: the induction of (multiple) gliomas.

Authors:  D A Bosch
Journal:  Acta Neurol Scand       Date:  1977-02       Impact factor: 3.209

View more
  14 in total

1.  Glial tumoral proliferation induces changes in the state and physical properties of water during ENU-induction of brain tumors in rats.

Authors:  V Rousseau; D Pouliquen; F Darcel; P Jallet; J J Le Jeune
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

2.  5'-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat.

Authors:  Taichang Jang; Joy M Calaoagan; Eunice Kwon; Steven Samuelsson; Lawrence Recht; Keith R Laderoute
Journal:  Int J Cancer       Date:  2011-05-01       Impact factor: 7.396

3.  Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.

Authors:  Taichang Jang; Todd Savarese; Hoi Pang Low; Sunchin Kim; Hannes Vogel; David Lapointe; Timothy Duong; N Scott Litofsky; James M Weimann; Alonzo H Ross; Lawrence Recht
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

4.  Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure.

Authors:  Gangadhara Reddy Sareddy; Sundaram Challa; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2009-01-16       Impact factor: 3.996

5.  Biochemical and histochemical evaluation of glycosaminoglycans in brain tumors induced in rats by nitrosourea derivatives.

Authors:  A Mauro; A Bertolotto; M T Giordana; M L Magrassi; A Migheli; D Schiffer
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

6.  Relationship between glial reaction to a stab wound and tumor development after receiving transplacental ethylnitrosourea in the rat.

Authors:  D Schiffer; M T Giordana; M C Vigliani; P Cavalla
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Effect of dietary vitamin A or N-acetylcysteine on ethylnitrosourea-induced rat gliomas.

Authors:  D A Ross; P Kish; K M Muraszko; M Blaivas; M Strawderman
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

8.  Microvascular abnormalities in ethylnitrosourea (ENU)-induced rat brain tumors: structural basis for altered blood-brain barrier function.

Authors:  S Nishio; M Ohta; M Abe; K Kitamura
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  Immunohistochemical observations on rat radial glia: relationship with the origin of ethylnitrosourea-induced tumors.

Authors:  M T Giordana; A Migheli; C Mocellini; F Villare; D Schiffer
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Vascular permeability and cell kinetics of ethylnitrosourea (ENU)-induced rat brain tumours.

Authors:  T Inoue; T Tashima; S Nishio; I Takeshita; T Iwaki; M Fukui
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.